Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Authors
Keywords
-
Journal
OPHTHALMOLOGY
Volume 130, Issue 7, Pages 735-747
Publisher
Elsevier BV
Online
2023-03-03
DOI
10.1016/j.ophtha.2023.02.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
- (2022) Jeffrey S Heier et al. LANCET
- Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
- (2022) Margaret A. Chang et al. JAMA Ophthalmology
- The learning curve of retinal detachment surgery
- (2021) Viola Radeck et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2021) Nancy M. Holekamp et al. OPHTHALMOLOGY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration
- (2018) Vincent Daien et al. OPHTHALMOLOGY
- Glaucoma Gel Implant Learning Curve in a Teaching Tertiary Hospital
- (2018) Raquel Esteves Marques et al. JOURNAL OF GLAUCOMA
- Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up
- (2016) Donald L. Budenz et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
- (2016) David G. Callanan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- The Ahmed Versus Baerveldt Study
- (2016) Panos G. Christakis et al. OPHTHALMOLOGY
- Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study
- (2015) Jonathan L. Prenner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration
- (2015) M Vukicevic et al. EYE
- Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
- (2015) Travis A. Meredith et al. OPHTHALMOLOGY
- Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
- (2015) Marc C. Peden et al. OPHTHALMOLOGY
- Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
- (2015) Rishma Gohil et al. PLoS One
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
- (2014) David S. Boyer et al. OPHTHALMOLOGY
- Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study
- (2014) Keith Barton et al. OPHTHALMOLOGY
- Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique
- (2014) Minwen Zhou et al. BMC Ophthalmology
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started